Article Sidebar
Published:
Aug 12, 2026Keywords:
Article Details
http://www.sajp.org.za/index.php/sajp/pages/view/policies#part_4
Copyright
The author(s) retain copyright on work published by AOSIS unless specified otherwise.
Licensing and publishing rights
Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose.
AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
Read more here: http://creativecommons.org/licenses/by/4.0/.
The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.
Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.
Main Article Content
Investigation of serum lactate dehydrogenase levels in generalised anxiety disorder
Abstract
Background: Lactate dehydrogenase (LDH) plays a crucial role in glucose metabolism by catalysing the conversion of pyruvate to lactate and facilitating lactate utilisation. Given LDH’s central role in energy metabolism, it may serve as a promising biomarker for anxiety disorders.
Aim: This study aimed to compare serum LDH levels between patients with generalised anxiety disorder (GAD) and healthy controls (HC) and to examine the associations between LDH levels and clinical features.
Setting: Bursa City Hospital: A tertiary hospital in Bursa, Turkey.
Methods: This study included 113 participants with GAD and 90 HC. Group comparisons were conducted using an independent samples t-test. Correlations between LDH levels and clinical variables were assessed using the Pearson rank correlation coefficient. To control for
the impacts of possible confounding factors on LDH levels, an analysis of covariance (ANCOVA) was conducted.
Results: Serum LDH levels were significantly lower in the GAD compared to the HC (157.7 ± 18.7 vs. 173.2 ± 23.3; p: <0.001, t: −5.249, d Cohen: 0.733). The ANCOVA analysis revealed that there was a statistically significant difference in adjusted LDH levels between
the control and GAD groups (p < 0.001; mean difference: −15.607; 95% confidence interval [CI]: −21.180 to −9.975). Additionally, LDH levels were negatively and significantly correlated with HAM-A scores (r = −0.218, p = 0.021) and psychic subscale scores (r = −0.250, p = 0.008).
Conclusion: These findings support the hypothesis that LDH may represent a potential biomarker and therapeutic target in the clinical management of anxiety.
Contribution: This study is the first to report significantly reduced LDH levels in individuals with GAD, highlighting a potential link between altered lactate metabolism and anxiety pathogenesis.
